UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[News Focus] Valsartan chaos reveals Korean drugmakers’ weakness
The pharmaceutical industry is having time for self-reflection, admitting t...
by So Jae-hyeon
|
2018-08-13 14:21
라인
Janssen Korea to observe 120 for post-marketing survey of ulcerative colitis treatment
The number of cases for additional indications of ulcerative colitis after ...
by Lee Hye-seon
|
2018-08-10 18:25
라인
Pfizer Vitals suffers double-whammy from poor performance, valsartan recall
Pfizer Vitals, which claimed to stand for quality generics, has suffered a ...
by So Jae-hyun
|
2018-08-10 17:56
라인
Cannabinoid group uses blockchain to conduct clinical trials on CBD
Kwon Yong-hyun (second from left), president of the Korean Cannabinoid Asso...
by Lee Han-soo
|
2018-08-10 14:53
라인
Daewoong, Chong Kun Dang compete to develop dementia treatments
The rivalry between Daewoong Pharmaceutical and Chong Kun Dang is getting i...
by So Jae-hyun
|
2018-08-09 15:55
라인
JW to launch drug combining Livaro, Ezetimibe
JW Pharmaceuticals has begun to develop a drug which combines two dyslipide...
by Lee Hye-seon
|
2018-08-09 11:59
라인
Competition heats up among Korean Botox makers to develop ‘kDa’
As the global expansion of domestic botulinum toxin (BTX) products is becom...
by So Jae-hyeon
|
2018-08-08 16:53
라인
GSK publishes SWORD data on 2-drug HIV regimen
ViiV Healthcare, the HIV specialty firm of GlaxoSmithKline, presented 100-w...
by Marian Chu
|
2018-08-08 14:42
라인
Takeda gets approval for antihypertension drug Edarbyclor
Takeda Pharmaceutical Korea said Tuesday it got approval for its antihypert...
by Marian Chu
|
2018-08-07 17:24
라인
Bukwang registers patients for P2 clinical trial of diabetes treatment
Bukwang Pharmaceutical said Tuesday that it has finished enrolling patients...
by Lee Han-soo
|
2018-08-07 17:24
라인
Over 36.8 billion won worth of banned valsartan-based drugs sold last year
More than 36.9 billion won worth of banned antihypertensive drugs were pres...
by So Jae-hyeon
|
2018-08-07 15:40
라인
59 Korea-made high blood pressure medications called back over cancer fears
Locally produced antihypertensive medication containing the active ingredie...
by Marian Chu
|
2018-08-06 17:50
라인
Chong Kun Dang gets license for generic immunosuppressant
Chong Kun Dang said it has obtained approval for Raparobell, a generic copy...
by So Jae-hyeon
|
2018-08-03 15:38
라인
GC Labcell, AbClon to develop CAR-NK cell treatment
GC Labcell CEO Park Dae-woo (left) and AbClon CEO Lee Jong-seo signed a coo...
by Lee Han-soo
|
2018-08-03 14:40
라인
Korean drugmakers rush to establish US subsidiaries
Local pharmaceutical companies are rushing to establish subsidiaries in the...
by So Jae-hyeon
|
2018-08-03 14:40
라인
Genexine, National OncoVenture to develop cervical cancer immunotherapy vaccine
Genexine said Thursday that it has signed an agreement with National OncoVe...
by Lee Han-soo
|
2018-08-02 17:33
라인
Expert advises against ‘doctor-shopping’ for uveitis treatment
A Korean expert noted the difficulties of treating uveitis in Korea, saying...
by Marian Chu
|
2018-08-02 15:37
라인
Pharmacists, convenience store owners in dispute over OTC drugs
The group of Korean pharmacists and that of convenience store owners are sl...
by So Jae-hyeon
|
2018-08-02 15:32
라인
Daewoong Bio’s dementia drug hits 3-digit sales growth
Industry watchers are paying attention to whether rising sales of generic d...
by So Jae-hyeon
|
2018-08-01 15:50
라인
GC increases in sales but loses profit in Q2
GC and its affiliates managed to increase its sales in the second quarter o...
by Lee Han-soo
|
2018-08-01 15:14
-
이전
71
72
73
74
75
76
77
78
79
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top